Precision medicine has yielded important breakthroughs in several branches of medicine, such as the development of drugs that target cells containing large amounts of HER2 (human epidermal growth factor receptor 2) in breast cancer (5). This evidence concerns the gene ERBB2 and breast carcinoma.